Table 1 Molecular traits (genes and proteins) with evidence of causal effects on T2D risk from eQTL and pQTL MR
eQTL | |||||||||
|---|---|---|---|---|---|---|---|---|---|
Blood | Subcutaneous adipose | Visceral adipose | Brain hypothalamus | Liver | Skeletal muscle | Pancreas | Pancreatic islets | ||
No. of significant causal effects | 335 | 243 | 186 | 90 | 70 | 217 | 139 | 131 | |
pQTL | EUR (n = 39) | HIBCH* | CPXM1* HIBCH* HYAL1 | HIBCH* | - | GSTA1* | CPXM1* HIBCH* | GSTA1* | PTGFRN HIBCH* |
AFR (n = 0) | - | - | - | - | - | - | - | - | |
EAS (n = 8) | - | - | - | - | - | BOC FAM20B | - | - | |
Meta-analysis (n = 5) | - | - | - | - | - | - | - | - | |